L-dopa--MAO inhibitors.
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*
D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine